Peter A Kiener
CIK 1328146 · Chief Science Officer · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$237.5K
Companies
4
Total Filings
34
Lifetime Open-Market Net
-$1.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUE | Director | 9,682 | $24.53 | $237.5K | -$392.3K | 11 | 2026-01-06 |
| LAVA Therapeutics NV (LVTX) Delisted | Director | — | $1.74 | — | $0 | 2 | 2025-11-17 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | — | $13.60 | — | $0 | 7 | 2023-06-23 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Chief Science Officer | 0 | — | — | -$825.0K | 14 | 2018-02-13 |
Recent Filings · Page 3 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-13 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Disp (D) | −44,856 | -$807.4K | EDGAR |
| 2018-01-04 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +329 | $3.0K | EDGAR |
| 2018-01-02 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Tax (F) | −27,496 | -$494.4K | EDGAR |
| 2017-12-11 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Mixed | — | -$408.5K | EDGAR |
| 2017-10-05 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +330 | $3.0K | EDGAR |
| 2017-07-07 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +336 | $3.0K | EDGAR |
| 2017-05-10 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +321 | $3.0K | EDGAR |
| 2017-03-08 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +70,000 | $0 | EDGAR |
| 2017-01-06 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +287 | $3.0K | EDGAR |
| 2016-10-21 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +320 | $3.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.